PSTV Projected Dividend Yield

Com Par $0.001/Plus Therapeutics Inc ( NASDAQ : PSTV )

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. Co. is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. Co. combines image-guided local beta radiation and targeted drug delivery approaches. Co. is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium (186Re) obisbemeda, is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC).

20 YEAR PERFORMANCE RESULTS

PSTV Dividend History Detail
PSTV Dividend News
PSTV Competitors News
# of Shares: 0 Closing Price: 1.27 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
2026 0.00 0% 0 $ 0.00 0.00%
2027 0.00 0% 0 $ 0.00 0.00%
2028 0.00 0% 0 $ 0.00 0.00%
2029 0.00 0% 0 $ 0.00 0.00%
2030 0.00 0% 0 $ 0.00 0.00%
2031 0.00 0% 0 $ 0.00 0.00%
2032 0.00 0% 0 $ 0.00 0.00%
2033 0.00 0% 0 $ 0.00 0.00%
2034 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor